Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $375
Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target from $315 to $375.
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.
Analyst Views West Pharmaceutical’s Q4 Earnings Impressive Despite Headwinds
West Pharmaceutical Services Inc (NYSE:WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth…
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell
• RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022.
• Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.
Where West Pharmaceutical Servs Stands With Analysts
West Pharmaceutical Servs (NYSE:WST) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…
Keybanc Maintains Overweight on West Pharmaceutical Servs, Lowers Price Target to $315
Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and lowers the price target from $350 to $315.
UBS Initiates Coverage On West Pharmaceutical Servs with Neutral Rating, Announces Price Target of $250
UBS analyst John Sourbeer initiates coverage on West Pharmaceutical Servs (NYSE:WST) with a Neutral rating and announces Price Target of $250.
West Pharmaceutical Servs’s Return On Capital Employed Overview
According to Benzinga Pro, during Q3, West Pharmaceutical Servs (NYSE:WST) earned $120.60 million, a 36.02% increase from the preceding quarter. West Pharmaceutical Servs's sales decreased to $686.90 million, a 10.94% change since Q2.
